how to inject myself with semaglutide Tutorial on how to inject
Description
Semaglutide 2.4mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection
You shouldn't take it if you're pregnant, breastfeeding, or planning a pregnancy in the next two months, or if you've had a serious allergic reaction to semaglutide
Experts debate GLP-1 drugs' long-term use as weight regain risks and evolving research shape the future.
Mrinalika RoyandSriparna Roy
Low-carb, high-protein diets help preserve lean mass and support long-term success.
